Published in Neuropsychopharmacology on March 14, 2007
Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology (2011) 2.79
Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/frontal cortex: the dampening action of antidepressants. PLoS One (2010) 1.16
Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania. Neuropharmacology (2008) 1.07
Serotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins. Psychopharmacology (Berl) (2012) 0.97
Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter--a review of current understanding of its mechanism of action. Psychopharmacology (Berl) (2011) 0.92
Nobiletin Ameliorates the Deficits in Hippocampal BDNF, TrkB, and Synapsin I Induced by Chronic Unpredictable Mild Stress. Evid Based Complement Alternat Med (2013) 0.87
Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways. BMC Neurosci (2010) 0.83
Altered expression of neuroplasticity-related genes in the brain of depressed suicides. Neuroscience (2015) 0.83
Ketamine regulates the presynaptic release machinery in the hippocampus. J Psychiatr Res (2013) 0.82
SKF83959 produces antidepressant effects in a chronic social defeat stress model of depression through BDNF-TrkB pathway. Int J Neuropsychopharmacol (2014) 0.78
Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes. BMC Neurosci (2013) 0.78
Antidepressants that inhibit both serotonin and norepinephrine reuptake impair long-term potentiation in hippocampus. Psychopharmacology (Berl) (2014) 0.76
Time-dependent activation of MAPK/Erk1/2 and Akt/GSK3 cascades: modulation by agomelatine. BMC Neurosci (2014) 0.75
Functional atlas of emotional faces processing: a voxel-based meta-analysis of 105 functional magnetic resonance imaging studies. J Psychiatry Neurosci (2009) 4.16
Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology (2011) 2.79
How can drug discovery for psychiatric disorders be improved? Nat Rev Drug Discov (2007) 2.29
Fear erasure in mice requires synergy between antidepressant drugs and extinction training. Science (2011) 2.25
ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria. Cell Microbiol (2012) 1.99
Brain anatomy and development in autism: review of structural MRI studies. Brain Res Bull (2003) 1.74
Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis. Neurosci Biobehav Rev (2007) 1.67
New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs. Br J Clin Pharmacol (2012) 1.62
Dynamic regulation of glutamatergic postsynaptic activity in rat prefrontal cortex by repeated administration of antipsychotic drugs. Mol Pharmacol (2008) 1.61
Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol Rev (2006) 1.51
Neuronal plasticity: a link between stress and mood disorders. Psychoneuroendocrinology (2009) 1.47
Metal fume fever. Lancet (2013) 1.43
Noradrenaline in mood and anxiety disorders: basic and clinical studies. Int Clin Psychopharmacol (2003) 1.34
Postnatal repeated maternal deprivation produces age-dependent changes of brain-derived neurotrophic factor expression in selected rat brain regions. Biol Psychiatry (2004) 1.32
Stress during development: Impact on neuroplasticity and relevance to psychopathology. Prog Neurobiol (2007) 1.31
Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum. J Biol Chem (2008) 1.30
Biosimilar drugs : concerns and opportunities. BioDrugs (2007) 1.26
Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus. J Neurosci (2005) 1.25
Mechanism and clinical significance of prostaglandin-induced iris pigmentation. Surv Ophthalmol (2002) 1.24
Optical coherence tomography of laryngeal cancer. Laryngoscope (2006) 1.23
Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades. Neuropsychopharmacology (2004) 1.23
Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels. Neuropsychopharmacology (2008) 1.21
The use of antidepressant drugs and the lifetime prevalence of major depressive disorders in Italy. Clin Pract Epidemiol Ment Health (2010) 1.20
Classical dengue hemorrhagic fever resulting from two dengue infections spaced 20 years or more apart: Havana, Dengue 3 epidemic, 2001-2002. Int J Infect Dis (2005) 1.17
Brain anatomy of persistent violent offenders: more rather than less. Psychiatry Res (2008) 1.17
Repeated exposure to cocaine differently modulates BDNF mRNA and protein levels in rat striatum and prefrontal cortex. Eur J Neurosci (2007) 1.17
Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. Learn Mem (2009) 1.16
Depression and Alzheimer's disease: neurobiological links and common pharmacological targets. Eur J Pharmacol (2009) 1.16
Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/frontal cortex: the dampening action of antidepressants. PLoS One (2010) 1.16
Experience-dependent expression of NPAS4 regulates plasticity in adult visual cortex. J Physiol (2012) 1.10
Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. Neuropsychopharmacology (2007) 1.10
Blood microRNA changes in depressed patients during antidepressant treatment. Eur Neuropsychopharmacol (2012) 1.08
Protective effects of a coumarin derivative in diabetic rats. Invest Ophthalmol Vis Sci (2009) 1.06
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients. Eur Neuropsychopharmacol (2006) 1.06
Isoflavones: estrogenic activity, biological effect and bioavailability. Eur J Drug Metab Pharmacokinet (2013) 1.05
Regulation of editing and expression of glutamate alpha-amino-propionic-acid (AMPA)/kainate receptors by antidepressant drugs. Biol Psychiatry (2006) 1.05
Glucocorticoid receptor and FKBP5 expression is altered following exposure to chronic stress: modulation by antidepressant treatment. Neuropsychopharmacology (2012) 1.04
TGF-beta 1 protects against Abeta-neurotoxicity via the phosphatidylinositol-3-kinase pathway. Neurobiol Dis (2008) 1.04
The action of antidepressants on the glutamate system: regulation of glutamate release and glutamate receptors. Biol Psychiatry (2012) 1.04
Association between promoter polymorphic haplotypes of interleukin-10 gene and schizophrenia. Biol Psychiatry (2002) 1.03
Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade. Eur J Pharmacol (2003) 1.03
Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depression. Eur Neuropsychopharmacol (2010) 1.02
Acute stress responsiveness of the neurotrophin BDNF in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine. Neuropsychopharmacology (2008) 1.02
Mode of action of agomelatine: synergy between melatonergic and 5-HT2C receptors. World J Biol Psychiatry (2011) 1.02
Serotonin triggers a transient epigenetic mechanism that reinstates adult visual cortex plasticity in rats. Eur J Neurosci (2010) 1.02
Optical coherence tomography of the newborn airway. Ann Otol Rhinol Laryngol (2008) 1.02
Potential role of probiotics on colorectal cancer prevention. BMC Surg (2012) 1.01
Fluoxetine and olanzapine have synergistic effects in the modulation of fibroblast growth factor 2 expression within the rat brain. Biol Psychiatry (2004) 1.00
Optical coherence tomography of the larynx in the awake patient. Otolaryngol Head Neck Surg (2008) 1.00
Antioxidants as antidepressants: fact or fiction? CNS Drugs (2012) 1.00
Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients. J Affect Disord (2006) 1.00
Pharmacological management of ocular hypertension: current approaches and future prospective. Curr Opin Pharmacol (2012) 0.99
Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats. Biochem Pharmacol (2012) 0.99
Simple determination of riluzole in rat brain by high-performance liquid chromatography and spectrophotometric detection. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.99
Cellular and molecular mechanisms in the long-term action of antidepressants. Dialogues Clin Neurosci (2008) 0.99
Small molecule activators of the Nrf2-HO-1 antioxidant axis modulate heme metabolism and inflammation in BV2 microglia cells. Pharmacol Res (2013) 0.98
Red orange: experimental models and epidemiological evidence of its benefits on human health. Oxid Med Cell Longev (2013) 0.98
Mediterranean diet and cancer: epidemiological evidence and mechanism of selected aspects. BMC Surg (2013) 0.97
Reduced neuroplasticity in aged rats: a role for the neurotrophin brain-derived neurotrophic factor. Neurobiol Aging (2013) 0.97
Gradient-index lens rod based probe for office-based optical coherence tomography of the human larynx. J Biomed Opt (2009) 0.97
Endocannabinoids and neurodegenerative diseases. Pharmacol Res (2007) 0.97
Sigma receptor ligands protect human retinal cells against oxidative stress. Neuroreport (2006) 0.97
Prenatal stress elicits regionally selective changes in basal FGF-2 gene expression in adulthood and alters the adult response to acute or chronic stress. Neurobiol Dis (2005) 0.96
Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus. Neuropharmacology (2007) 0.96
TGF-β1 pathway as a new target for neuroprotection in Alzheimer's disease. CNS Neurosci Ther (2009) 0.96
The pharmacological properties of antidepressants. Int Clin Psychopharmacol (2010) 0.96
Dysfunction of TGF-β1 signaling in Alzheimer's disease: perspectives for neuroprotection. Cell Tissue Res (2011) 0.95
Early-life stress and antidepressants modulate peripheral biomarkers in a gene-environment rat model of depression. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.95
The lifetime prevalence of bipolar disorders and the use of antidepressant drugs in bipolar depression in Italy. J Affect Disord (2011) 0.95
Alexithymia in healthy women: a brain morphology study. J Affect Disord (2008) 0.94
Laparoscopic vs. open approach for colorectal cancer: evolution over time of minimal invasive surgery. BMC Surg (2013) 0.94
Repeated stress prevents cocaine-induced activation of BDNF signaling in rat prefrontal cortex. Eur Neuropsychopharmacol (2009) 0.94
Physical exercise and antidepressants enhance BDNF targeting in hippocampal CA3 dendrites: further evidence of a spatial code for BDNF splice variants. Neuropsychopharmacology (2012) 0.94
Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis. J Neurochem (2011) 0.94